Endocrinology

Top Story

IDF, Eli Lilly launch second phase of international diabetes prevention initiative

IDF, Eli Lilly launch second phase of international diabetes prevention initiative
June 25, 2017

The International Diabetes Federation and Eli Lilly are launching the second phase of a program to help people with diabetes effectively manage their disease, according to a press release.

The second iteration of the Bringing Research in Diabetes to Global Environments and Systems program (BRIDGES 2) will implement diabetes prevention interventions internationally, building on the initial phase, which operated from 2007 to 2015.

Ascensia, Voluntis to combine technologies

June 24, 2017
Ascensia Diabetes Care and Voluntis are initiating a technology partnership, linking their blood glucose monitors and insulin management system, according to a press…
In the Journals Plus

Several medications safe for comanagement of type 2 diabetes, osteoporosis

June 23, 2017
A recent comprehensive review published in The Journal of Clinical Endocrinology & Metabolism identifies metformin, sulfonylureas, DPP-IV inhibitors and GLP-1…
In the Journals Plus

Maintained weight loss for 1 year increases insulin sensitivity in women

June 23, 2017
Women with overweight or obesity who maintained at least 15% reduction in body weight for 12 months were more likely to have improved insulin sensitivity when compared…
In the Journals Plus

Childhood fractures not predictive of BMD, bone strength in young men

June 23, 2017
The occurrence of fractures in boys did not predict bone fragility of men in early adulthood, study data from Switzerland and the Netherlands showed.
More News Headlines »
CME

Practical Lipidology®: Volume 3, Number 2

This activity is supported by an educational grant from Amgen

The reduction of low-density lipoprotein-cholesterol (LDL-C) is recognized as the primary strategy for decreasing…
More »
Video
Meeting News

VIDEO: Beta-cell replacement will be future of diabetes care

June 9, 2017
More »
Featured
The Endocrine Society Annual Meeting

The Endocrine Society Annual Meeting

CNE CME CPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement